公开(公告)号：WO2013128419A3

公开(公告)日：2013-11-21

申请号：PCT/IB2013051644

申请日：2013-03-01

Applicant: REDDYS LAB LTD DR

Inventor： VAYA NAVIN ,  PRABHAKAR BHAGWATWAR HARSHAL ,  BANDICHHOR RAKESHWAR ,  KHATI NIRMAL ,  SHAIK RIYAZ AHMED ,  BHISE RAHUL ,  ASALLA YAKASWAMY ,  SHINDE RAJKUMAR BHIMRAO

IPC: A61K31/4985 ,  A61K9/08 ,  A61K38/05 ,  A61K47/12 ,  A61P35/00

CPC classification number: A61K47/18 ,  A61K31/133 ,  A61K31/194 ,  A61K31/497 ,  A61K31/69 ,  A61K47/12 ,  C07F5/025 ,  A61K2300/00

Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6.0.

Abstract translation: 药物组合物及其制备方法。 组合物包含硼替佐米或其药学上可接受的盐或溶剂化物，氨丁三醇和有机羧酸，组合物的pH为约3.0至6.0。

公开(公告)号：WO2013008253A2

公开(公告)日：2013-01-17

申请号：PCT/IN2012000488

申请日：2012-07-11

Applicant: REDDYS LAB LTD DR ,  KONATHAM SURESH ,  MALLADI MADHUSUDAN ,  VURE PRASAD ,  BISWAS MOUMITA ,  BHISE RAHUL ,  KOTA RAMESH

Inventor： KONATHAM SURESH ,  MALLADI MADHUSUDAN ,  VURE PRASAD ,  BISWAS MOUMITA ,  BHISE RAHUL ,  KOTA RAMESH

CPC classification number: A61K9/284 ,  A61K9/1617 ,  A61K9/2013 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/4858 ,  A61K31/506

Abstract: Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient.

Abstract translation: 本申请的方面涉及包含伊马替尼或其盐，异构体，外消旋体，对映异构体，水合物，溶剂合物，代谢物和多晶型物及其混合物的药物制剂。 其它方面涉及制备包含伊马替尼或其盐以及至少一种药学上可接受的赋形剂的药物制剂的方法。

公开(公告)号：EP2819673A4

公开(公告)日：2015-03-18

申请号：EP13755443

申请日：2013-03-01

Applicant: REDDYS LAB LTD DR

Inventor： VAYA NAVIN ,  PRABHAKAR BHAGWATWAR HARSHAL ,  BANDICHHOR RAKESHWAR ,  KHATI NIRMAL ,  SHAIK RIYAZ AHMED ,  BHISE RAHUL ,  ASALLA YAKASWAMY ,  SHINDE RAJKUMAR BHIMRAO

IPC: A61K38/05 ,  A61K9/08 ,  A61K31/133 ,  A61K31/194 ,  A61K31/497 ,  A61K31/69 ,  A61K47/12 ,  A61P35/00

CPC classification number: A61K47/18 ,  A61K31/133 ,  A61K31/194 ,  A61K31/497 ,  A61K31/69 ,  A61K47/12 ,  C07F5/025 ,  A61K2300/00

公开(公告)号：CA2866135A1

公开(公告)日：2014-09-06

申请号：CA2866135

申请日：2013-03-01

Applicant: REDDYS LAB LTD DR

Inventor： VAYA NAVIN ,  PRABHAKAR BHAGWATWAR HARSHAL ,  BANDICHHOR RAKESHWAR ,  KHATI NIRMAL ,  SHAIK RIYAZ AHMED ,  BHISE RAHUL ,  ASALLA YAKASWAMY ,  SHINDE RAJKUMAR BHIMRAO

IPC: A61K31/4985 ,  A61K9/08 ,  A61K38/05 ,  A61K47/12 ,  A61P35/00

Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6Ø

公开(公告)号：AU2013227219A1

公开(公告)日：2014-10-23

申请号：AU2013227219

申请日：2013-03-01

Applicant: REDDYS LAB LTD DR

Inventor： VAYA NAVIN ,  PRABHAKAR BHAGWATWAR HARSHAL ,  BANDICHHOR RAKESHWAR ,  KHATI NIRMAL ,  SHAIK RIYAZ AHMED ,  BHISE RAHUL ,  ASALLA YAKASWAMY ,  SHINDE RAJKUMAR BHIMRAO

IPC: A61K31/4985 ,  A61K9/08 ,  A61K38/05 ,  A61K47/12 ,  A61P35/00

Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6.0.

公开(公告)号：IN1009CHN2014A

公开(公告)日：2015-04-10

申请号：IN1009CHN2014

申请日：2014-02-07

Applicant: REDDYS LAB LTD DR

Inventor： KONATHAM SURESH ,  MALLADI MADHUSUDAN ,  VURE PRASAD ,  BISWAS MOUMITA ,  BHISE RAHUL ,  KOTA RAMESH

IPC: A61K9/00 ,  A61K9/14 ,  A61K31/506

Abstract: Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts isomers racemates enantiomers hydrates solvates metabolites and polymorphs and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts together with at least one pharmaceutically acceptable excipient.